Brief: Promore Pharma Receives Approval For Phase IIb Trial With LL-37

PMD Device Solutions AB

03/07/2018 06:32

July 3 (Reuters) - PROMORE PHARMA AB  PROMO.ST :
    * PROMORE PHARMA RECEIVES APPROVAL FOR PHASE IIB TRIAL WITH
LL-37
    * PRIMARY END POINT IS PROPORTION OF PATIENTS THAT HAVE
COMPLETE
HEALED WOUNDS

Source text for Eikon:  ID:nWkr5Hh2kd 
Further company coverage:  PROMO.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))